Viewing Study NCT04924192


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-26 @ 1:10 PM
Study NCT ID: NCT04924192
Status: UNKNOWN
Last Update Posted: 2021-09-21
First Post: 2021-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module